Aspen grows Latin American assets with R5bn Viagra deal | Business

📆 01/08/2023 14:30:00
📰 News24

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 80%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

SA's biggest pharmaceutical group, Aspen Pharmacare, is deepening its footprint in Latin America with the $280 million (R5 billion) acquisition of a portfolio of specialist drugs, including Viagra. | News24_Business

Among other key products in the portfolio are cholesterol-lowering medicine Lipitor, anti-epileptic drug Lyrica, antidepressant Zoloft, hypertension medicine Norvasc and Celebrex, an anti-inflammatory medication. These are being acquired from Nasdaq-listed drug maker Viatris, with Aspen paying $150 million in cash for the portfolio and settling the balance through an extension of supply terms to Viatris.

"Due to the way the products have been integrated into Viatris' business, it is not possible to accurately determine or estimate the profit attributable to the products within Viatris," the group said.

Escrever Comentário

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Aspen seeks to lift Latin American business in R5bn deal with ViatrisThe drugmaker secured the commercialisation rights and related intellectual property for products such as Viagra and Lipitor
Fonte: BDliveSA - 🏆 12. / 63 Consulte Mais informação »

Into Africa – the insurance industry is burgeoningApio Group has formally rebranded to Olea South Africa after becoming part of Olea Group of companies in 2021.
Fonte: BusinessTechSA - 🏆 24. / 61 Consulte Mais informação »